In a prospective cohort study, Riedl et al. explored the association of intratumoral PDPN expression with hypercoagulability, intratumoral platelet aggregation, VTE risk, and mortality in patients with primary brain tumors [27]. Here, PDPN is linked to brain neoplasm.